Drug Discovery Today
||This article contains content that is written like an advertisement. (July 2017) (Learn how and when to remove this template message)|
Drug Discovery Today is a monthly peer-reviewed scientific journal that is published by Elsevier. It was established in 1996 and publishes reviews on all aspects of preclinical drug discovery from target identification and validation through hit identification, lead identification and optimisation, to candidate selection.
In 2004, the Drug Discovery Today journal series expanded with the launch of four online-only review journals: Drug Discovery Today: Disease Mechanisms, Drug Discovery Today: Disease Models, Drug Discovery Today: Therapeutic Strategies, and Drug Discovery Today: Technologies. The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline.
|This article about a scientific journal on pharmacology is a stub. You can help Wikipedia by expanding it.
See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.